Orange Book product · Brand (NDA)
QVAR REDIHALER
BECLOMETHASONE DIPROPIONATE
At a glance
Aug 03, 2017
Approved
Brand (NDA)
Application
Not listed
TE code
17
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 03, 2017
9 yr ago
Today
Patent 8132712 expires
Listed drug product patent expiration.
Sep 07, 2028
in 2 yr 3 mo
Patent 10022509 expires
Listed drug product patent expiration.
May 18, 2031
in 5 yr
Patent 10022510 expires
Listed drug product patent expiration.
May 18, 2031
in 5 yr
Patent 10086156 expires
Listed drug product patent expiration.
May 18, 2031
in 5 yr
Patent 10695512 expires
Listed drug product patent expiration.
May 18, 2031
in 5 yr
Patent 11395889 expires
Listed drug product patent expiration.
May 18, 2031
in 5 yr
Patent 8931476 expires
Listed drug product patent expiration.
Jul 17, 2031
in 5 yr 2 mo
Patent 10561808 expires
Listed drug product patent expiration.
Jan 01, 2032
in 5 yr 7 mo
Patent 11395888 expires
Listed drug product patent expiration.
Jan 26, 2038
in 11 yr 9 mo
Patent 11793953 expires
Listed drug product patent expiration.
Jan 26, 2038
in 11 yr 9 mo
Patent 11865247 expires
Listed drug product patent expiration.
Jan 26, 2038
in 11 yr 9 mo
Patent 11896759 expires
Listed drug product patent expiration.
Jan 26, 2038
in 11 yr 9 mo
Patent 12296089 expires
Listed drug product patent expiration.
Jan 26, 2038
in 11 yr 9 mo
Patent 10792447 expires
Listed drug product patent expiration.
Jan 25, 2039
in 12 yr 9 mo
Patent 11559637 expires
Listed drug product patent expiration.
Jul 21, 2039
in 13 yr 3 mo
Patent 11957832 expires
Listed drug product patent expiration.
May 05, 2041
in 15 yr 1 mo
Patent 11583643 expires
Listed drug product patent expiration.
Aug 19, 2041
in 15 yr 5 mo
Pharmaceutical detail
Active ingredient
BECLOMETHASONE DIPROPIONATE
Strength
0.08MG/INH
Dosage form
AEROSOL, METERED
Route
INHALATION
TE code
Not listed
Application
NDA 207921
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2014QNASLBrand (NDA)
NDA 202813 · TEVA BRANDED PHARM
- 2000QVAR 40Brand (NDA)
NDA 020911 · TEVA BRANDED PHARM
- 1996VANCERIL DOUBLE STRENGTHBrand (NDA)
NDA 020486 · SCHERING
- —BECLOVENTBrand (NDA)
NDA 018153 · GLAXOSMITHKLINE
- —VANCERILBrand (NDA)
NDA 017573 · SCHERING
- —BECONASEBrand (NDA)
NDA 018584 · GLAXOSMITHKLINE
- —VANCENASEBrand (NDA)
NDA 018521 · SCHERING
- 2025BECLOMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 213811 · AMNEAL IRELAND LTD
Listed patents (17)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8132712 | Sep 07, 2028 | in 2 yr 3 mo | ProductDelisted |
| 10022509 | May 18, 2031 | in 5 yr | ProductDelisted |
| 10022510 | May 18, 2031 | in 5 yr | ProductDelisted |
| 10086156 | May 18, 2031 | in 5 yr | ProductDelisted |
| 10695512 | May 18, 2031 | in 5 yr | ProductDelisted |
| 11395889 | May 18, 2031 | in 5 yr | ProductDelisted |
| 8931476 | Jul 17, 2031 | in 5 yr 2 mo | Product |
| 10561808 | Jan 01, 2032 | in 5 yr 7 mo | ProductDelisted |
| 11395888 | Jan 26, 2038 | in 11 yr 9 mo | Product |
| 11793953 | Jan 26, 2038 | in 11 yr 9 mo | Product |
| 11865247 | Jan 26, 2038 | in 11 yr 9 mo | ProductDelisted |
| 11896759 | Jan 26, 2038 | in 11 yr 9 mo | ProductDelisted |
| 12296089 | Jan 26, 2038 | in 11 yr 9 mo | Product |
| 10792447 | Jan 25, 2039 | in 12 yr 9 mo | Product |
| 11559637 | Jul 21, 2039 | in 13 yr 3 mo | Product |
| 11957832 | May 05, 2041 | in 15 yr 1 mo | Product |
| 11583643 | Aug 19, 2041 | in 15 yr 5 mo | Product |
